




Therapeutic efficacy testing of two topical products used in dry 
demodicosis lesions in dogs from Mehedinti County 
 
Narcisa MEDERLE1, Alpaslan KAYA2, Mădălina ALBU KAYA3, Mariana PĂTRAȘCU4, Sylviu 
KUMBAKISAKA4, Sorin MORARIU1, Andreea GARTNER1, Adina NEGRESCU5, 
Gheorghe DĂRĂBUȘ1 
 
1Banat’s University of Agricultural Sciences and Veterinary Medicine ”King Michael I of Romania” 
from Timisoara, Faculty of Veterinary Medicine, Timisoara, Romania 
2 Mustafa Kemal University, Faculty of Agriculture, Department of Field Crops, Antakya-Hatay, 
Turkey 
3 The National Research and Development Institute for Textile and Leather, The Department of 
the Leather and Shoes Research Institute, Bucharest, Romania 
4 Primosal Ltd, Bucharest, Romania 




Canine demodicosis is a serious dermatitis, difficult to treat, often recurrent, and the biology and 
pathogenesis of the aetiological agent prevent the action of drugs on skin. The aim of the study was to 
evaluate the therapeutic efficacy in dry canine demodicosis of two products: Ointment Canider (containing 
formamidine) and Demosymcan - gel whose components are natural and fixed in fast absorbing gels. The 
results obtained were statistically interpreted from the clinical and parasitological healing point of view 
(erythema, alopecia, squamae, hyperseboree, microscopic examination of the cutaneous scraping) and were 
calculated: scores averages, medians, standard deviations, minimum and maximum values. The clinical 
signs remission and negative microscopic examination of skin scraping from lesions were reported at 9 and 
15 weeks in group I treated with the product based on honey, propolis, apple vinegar and extracts plant and 
12 and 16 weeks, respectively, in lot II, where the product was based on amitraz and neomycin. Exacerbation 
of clinical signs and presence of mite in microscopic slides were revealed in the control group, to which a 
gel containing no ingredient was applied. 
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Introduction 
Cutaneous parasitosis, demodicosis is diagnosed in a number of domestic and wild animals: 
carnivores, rodents, ruminants, insectivores. It is produced by Demodex species, the only genus of 
the Demodecidae family. A short history of the drug used in canine demodicosis over a hundred 
years confirms the claim that canine demodicosis is a serious dermatitis, difficult to treat, often 
recurrent, and the biology and pathogenesis of the aetiological agent prevent the action of drugs on 
skin (1, 8, 10, 11). 
Current information on canine demodicosis is focused on therapy. While most authors use 
the acaricides treatment by spot-on (moxidectin-imidacloprid), oral or systemic administration of 
avermectin and milbemycin or topical applications of formamidines, other authors recommend 
non-irritating and non-invasive skin and body products (2, 3, 5, 6, 7, 10, 11, 12). 
Taking into account the high prevalence of canine demodicosis in our country and in the 
world, the complex therapeutic approaches and the specialists emphased recommandation natural 
product, without irritating effects on demodectic skin, the aim of the study was to evaluate the 
therapeutic efficacy of two products: Ointment Canider (containing formamidine) and 





Materials and methods 
A total of 62 dogs, different breeds, males and females, aged 3-48 months, were selected for 
this study. The dogs had dry localized cutaneous lesions manifested by: erythema, alopecia, fine 
squamae, whitish, hyperseboree. The lesion distribution was: periocular, cheek, ears, lips, ventral 
cervical region, olecranic region, anterior forearm, dorsal lumbar region, trunk, posterior legs. The 
dogs belonged to the Veterinary Districts of Greci, Şimian, Tâmna, Mehedinţi County. The dogs 
were divided into three groups. 
Lot I - 22 dogs to which the product Demosymcan Gel was applied for the treatment of dry 
lesions in canine demodicosis 
Gel for the treatment of dry lesions in canine demodicosis - is an original product produced 
by the Parasitology Department team - VMF Timisoara, in collaboration with The National Research 
and Development Institute for Textile and Leather, Bucharest. The gel is OSIM registered as patent 
application no. A 00075/ 1.02.2016. The invention refers to a gel for the treatment of dry canine 
demodycosis lesions produced in dogs by mite Demodex spp. and it based on of the main 
components from honey, propolis, apple vinegar and hydro-glycero-alcoholic extracts from the 
buds of various plants. 
The product was awarded at the National and International Salons of Inventions (Iasi, Cluj, 
Timisoara, Bucharest, Brussels, Geneva, Barcelona) where it won 7 gold medals and 8 special 
prizes (Fig.1). 
 





Lot II - 20 dogs to which the Canider Ointment product was applied (contains amitraz and 
neomycin sulfate). Lot III, the control group - 20 dogs to which a gel wich containing no ingredient. 
The dogs were followed weekly for a period of 3 months. Monitoring began one week after 
the treatment onset and continued after clinical and parasitological healing. 
The results obtained were statistically interpreted from the clinical and parasitological 
healing point of view (erythema, alopecia, squamae, hyperseboree, microscopic examination of the 
cutaneous scraping) and were calculated: scores averages, medians, standard deviations, minimum 
and maximum values. 
 
Results and discussions 
By corroborating the results of the anamnesis, the clinical and dermatological 
examinations, the diagnosis of demodicosis was established (Figures 2, 3, 4, 5). 
 
Fig. 2. Descuamation Fig. 3. Alopecia 
 
Fig. 4. Erythema Fig. 5.  Hyperseboree 
 
 
The demodicosis diagnosis was confirmed by microscopy. The life stages of Demodex 







Fig. 6. Demodex canis 
 
Each patient's record sheet contained all patient information. Clinical signs (erythema, 
alopecia, squamae, hyperseboree) and microscopical examination of skin scraping have been 
evaluated weekly on a scale of 0-5. 
The results of the clinical and parasitological evolution of each group during the 12 weeks 
of treatment are shown in Table 1. 
 
Table 1: The clinical and parasitological evolution results 
 
Săptămâna Lot I (Demosymcan) Lot II (Canider U) Lot III (Gel) 
E. A. S. H. P.H. E. A. S. H. P.H. C.H. P.H. 
1 5 5 5 5 5 5 5 5 5 5 5 5 
2 4 5 5 4 5 5 5 5 5 5 5 5 
3 3 4 5 3 5 5 4 4 5 5 5 5 
4 2 4 3 3 5 4 4 4 4 5 5 5 
5 1 3 1 1 5 4 3 3 4 4 5 5 
6 0 3 0 0 4 3 2 2 4 4 5 5 
7 0 2 0 0 3 3 2 1 3 3 5 5 
8 0 1 0 0 3 2 1 1 2 3 5 5 
9 0 0 0 0 2 1 1 0 1 2 5 5 
10 0 0 0 0 2 0 1 0 1 2 6 5 
11 0 0 0 0 1 0 0 0 1 1 6 5 
12 0 0 0 0 1 0 0 0 0 1 6 5 
 
Legend: E - erythema, A - alopecia, S - squamae, H - hyperseboree, P.H. - parasitological 





Descriptive statistic establishes significant differences between the three groups. In group I 
treated with Demosymcan Gel, clinical and parasitological recovery were significant (p = 0.000 
<0.05, respectively p = 0.003). The results of the statistic test indicate that Demosymcan Gel has 
the highest therapeutic efficacy. 
It is widely accepted that the successful treatment of this parasitosis involves knowing the 
biology of the parasite, making it difficult to find an acaricide that is efficient against mites and, at 
the same time, harmless to the dog, the skin being a rather fragile structure when contacted with 
the therapeutic substances (1, 7, 10, 11). 
The presence of Demodex mite leads to a change in skin microclimate: alkalinisation of pH, 
changes in the composition of the lipid layer, increase in the concentration of fatty acids, reactions 
leading to an irritant effect of most topical formulations. More over, the complex mechanism of 
skin absorption is influenced by the nature of the base, the condition of the skin and the biological 
factors. 
15 years ago, the first therapeutic study in canine demodicosis was initiated using a non- 
acaricid product (8). The results obtained were re-evaluated and developed, and the final result is 
the Demosymcan Gel Patent Application for the treatment of dry lesions from canine demodicosis, 
product used for group I. 
The results of the present study reveal a higher therapeutic efficacy of the above-mentioned 
product compared to the Canider U, the clinical healing and the negative microscopic examination 
of the skin scraping being noted in a shorter time in group I (at 8 weeks and 14 weeks after the 
onset of treatment), compared to group II. 
At international level, there are therapeutic studies that support the treatment of canine 
demodicosis with herbal substances, plant extracts, non-irritating for skin but efficient in remitting 
clinical signs and in parasitic healing: the Maggacite product administered twice a day, the 
Homeopathic, Product Graphitis 200 administered daily, AV / EPP / 14, Gliricidia (Gliricidia 
sepium decoction), Dermanol, Anbioflam, Immuplus, Ectozee (6, 9). 
This comparative therapeutic study between a synthesis product, Canider U, containing 
amitraz and neomycin (lot II) and a natural product, Demosymcan Gel, containing honey, propolis, 
apple vinegar and hydro-glycero-alcohol extracts from the buds of various plants (group I) revealed 
a remission of clinical sign at 8 weeks after the onset of treatment and a negation of the microscopic 
examination of cutaneous lesions at 14 weeks after the onset of treatment - group I over the longer 
time- it requires the treatment applied to group II, a result that joins the research that recomand 
natural, non-invasive therapy for skin. 
A therapeutical study (4) conducted in Craiova on a group of 66 dogs diagnosed with 
demodicosis and treated with Demosymcan Gel (Lot I) and Canider U (Lot II) allows us to 
highlight the comparative results: remission of clinical sign (erythema, alopecia, squamae, 
hyperseboree) and the negative microscopic examination of cutaneous scraping from lesions were 
reported at 8 and 14 weeks in group I treated with the product containing honey, propolis, apple 
vinegar and vegetable extracts, and at 12 and 16 weeks respectively in group II, where the product 
was based on amitraz and neomycin. The results of this study reveal that clinical and parasitological 
healing have been achieved in a shorter time compared to the results of the therapeutic researches 
carried out in the dogs in Mehedinţi County (4). 
 
Conclusions 
The clinical signs remission (erythema, alopecia, squamae, hyperseboree) and negative 





treated with the product containing honey, propolis, apple vinegar and extracts plant and 12 and 16 
weeks, respectively, in lot II, where the product was based on amitraz and neomycin. 
Exacerbation of clinical signs and presence of mite in microscopic slides were revealed in 
the control group, to which a gel containing no ingredient was applied. 
We recommend Demosymcan Gel for treatment of dry lesions in canine demodicosis, 
applied daily on lesions. 
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